MedTrace Logo

Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia

NCT03333473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9282

Last updated 2021-08-17

No results posted yet for this study

Summary

The primary goal of PPFP Choices is to generate actionable evidence that can be used to increase programmatic activities to address post-pregnancy family planning in the public and private-for-profit sectors. The ultimate intent of this investment is to advance and scale up post-pregnancy FP. Programmatic learning will be crucial to understanding what it will take to accelerate post-pregnancy FP in these two countries, and these can later be adapted by other countries with similar settings. Our vision of PPFP Choices can be achieved through the following objectives:

* Objective 1: Establish a comprehensive program implementation framework for the private sector to embrace post-pregnancy FP
* Objective 2: Improve the quality of post-pregnancy FP counseling and service provision in both public and private sectors
* Objective 3: Build evidence and contribute to the literature and programmatic guidance around post-pregnancy FP uptake and continuation in both public and private sectors
* Objective 4: Ensure effective documentation and strategic dissemination which will benefit post-pregnancy FP introduction and scale-up more broadly

Conditions

  • Post-pregnancy Family Planning
  • Capacity Building of Healthcare Providers

Interventions

BEHAVIORAL

PPFP Clinical and Counseling Skills

Facilities will receive whole-site orientations on PPFP basics and skills Through training of trainers, followed by classroom and model-based and clinical-based practice, providers will receive training in PPDP counseling and service provision.

BEHAVIORAL

Facility-Level Leadership Management and Governance Training

The intervention will strengthen leadership management and governance practices required to help managers establish PPFP services at the facility level.

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Merck for Mothers

    collaborator OTHER

  • Jhpiego

    lead OTHER

Principal Investigators

  • Elaine Charurat, MBA, MHS · Jhpiego

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-09
Primary Completion
2020-03-16
Completion
2020-03-16

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03333473 on ClinicalTrials.gov